CORFLOW COMPLETES CLOSE OF SEED+ FINANCING ROUND.

The article offers information on completion of CorFlow Therapeutics AG's closure of Seed+ financing round in the field of interventional cardiology technologies. It mentions efforts of the company to raise seed funding which will be used to finance Metformin in Obese Children and Adolescents (MOCA) clinical trial in Europe. It also states that the MOCA trial will investigate diagnosis of microvascular obstruction in acute coronary patients along with treatment methods.